Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
10/2009
10/13/2009US7601733 5(S)-(2′-hydroxyethoxy)-20(S)-camptothecin and its preparation and use for the treatment of cancer
10/13/2009US7601732 Anticancer agents; 5(R)-(2''-hydroxyethoxy)-20(S)-camptothecin; X-ray powder diffraction
10/13/2009US7601730 Carboxylic acid derivatives, their preparation and use
10/13/2009US7601725 Such as 1-[3-(2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-5-fluoro-phenyl]-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)-ethyl]-thiazol-2-yl}-urea
10/13/2009US7601719 Compounds, methods and pharmaceutical compositions for inhibiting PARP
10/13/2009CA2386974C Benzodiazepine derivatives for use in acute or chronic neurological disorders
10/13/2009CA2341678C Potassium channel inhibitors and method
10/08/2009WO2009121247A1 Luminescence quenchers and fluorogenic probes for detection of reactive species
10/08/2009WO2008080844A9 Azaspiro derivatives
10/08/2009US20090253915 Novel epoxy compounds and method for production of the same
10/08/2009US20090253694 Fused hetrocyclic compounds
10/08/2009US20090253691 Trisubstituted 1,2,4-triazoles
10/08/2009US20090253682 Heterocyclic derivatives for modulation of calcium channels
10/08/2009US20090253653 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
10/08/2009US20090253148 FLUORESCENCE POLARIZATION hERG ASSAY
10/07/2009EP1235595B8 Integrin-mediated drug targeting
10/07/2009EP0741700B1 1-h-3-arylpyrrolidine-2,4-dione derivatives as pest-control agents
10/07/2009EP0572557B1 Use of topotecan in the manufacture of a medicament for use in the treatment of ovarian cancer
10/07/2009CN101553493A Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity
10/07/2009CN101553492A RAF inhibitor compounds and methods of use thereof
10/07/2009CN101550119A Aryl (ethanoic) propanoic acid ascorbyl ester, preparation method thereof and medicament containing same
10/07/2009CN101550103A 1, 2, 3, 4-tetrahydroisoquinoline derivatives and synthetic method and uses thereof
10/07/2009CN101550072A Effective component of cogongrass rhizome and preparation method thereof
10/06/2009US7598386 Sulphones which modulate the action of gamma-secretase
10/06/2009US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
10/06/2009US7598375 For making maytansinoids with chiral amino acid side chains; maytansinoids may be conjugated to cell-binding agents such as antibodies and are useful therapeutics, especially for treatment of cancer; high yielding methods that avoid or reduce epimerization in coupling of side chain linker
10/06/2009US7598264 HIV integrase inhibitors
10/06/2009US7598261 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor and may be useful, inter alia, for treating and/or preventing pain, anxiety, gastrointestinal disorders, and other delta opioid receptor-mediated conditions; minimized undesirable side effects
10/06/2009US7598259 mGluR1 antagonists as therapeutic agents
10/06/2009US7598255 Pyrimidine compounds as serotonin receptor modulators
10/06/2009US7598236 Diazabicyclic central nervous system active agents
10/01/2009WO2009120890A1 Dioxolane and dioxolanone fused indolobenzadiazepine hcv ns5b inhibitors
10/01/2009WO2009120652A2 Monocyclic cgrp receptor antagonists
10/01/2009WO2009119726A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
10/01/2009WO2009119088A1 Heterocyclic compound
10/01/2009WO2009119086A1 Method for producing 9-hydroxymethyl-cyclohepta[b]pyridine-3-carboxylate ester derivative
10/01/2009WO2009118173A1 Substituted spirocyclic cyclohexane derivatives
10/01/2009WO2009060835A8 Novel ubiquilin-binding small molecule
10/01/2009US20090247745 adenosine A3 receptor antagonists; improved bioavailability; treatment of diseases such as asthma, COPD and ARDS, glaucoma, tumor, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases; e.g. 4-Methoxy-N-[6-(morpholin-4-yl)-4-benzylamino-3-cyanoquinolin-2-yl]-benzamide
10/01/2009US20090247569 Process for Preparing Clopidogrel Bisulphate
10/01/2009US20090247567 Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use
10/01/2009US20090247566 Pyrano [3,2-C] Pyridones and Related Heterocyclic Compounds as Pharmaceutical Agents for Treating Disorders Responsive to Apoptosis, Antiproliferation or Vascular Disruption, and the Use Thereof
10/01/2009US20090247565 receptor tyrosine kinase MET inhibitors; anticancer agents; 8-phenyl-10H-furo[2',3':4,5]cyclohepta[1,2-b]pyridin-10-one
10/01/2009US20090247561 Substituted spirocyclic cyclohexane derivatives
10/01/2009US20090247471 Inhibitors of cruzipain and other cysteine proteases
10/01/2009CA2719742A1 Substituted spirocyclic cyclohexane derivatives
10/01/2009CA2718727A1 Heterocyclic compound
10/01/2009CA2717384A1 Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
09/2009
09/30/2009EP2104677A1 Spiropiperidine glycinamide derivatives
09/30/2009EP2104676A2 Methods for preparing arene-bis(dicarboximide)-based semiconducting materials and related intermediates for preparing same
09/30/2009EP2104670A2 Novel triazinedione derivatives as gaba-b receptor modulators
09/30/2009EP1910376B1 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds
09/30/2009EP1554290B1 Analogs and prodrugs of buprenorphine
09/30/2009CN101544651A Method for synthesizing polysubstitution pyridinone compounds
09/29/2009US7595400 Synthesis of antitumor agents including camptothecin derivative 9-ethyl-9-hydroxy-1-pentyl-1H,12H-pyrano[3'',4'':6',7']-indolizino[1',2':6,5]pyrido[4,3,2-de]quinazoline-10,13(9H,15H)-dione
09/29/2009US7595349 Thermally cleavable surfactants
09/29/2009US7595344 Sulphones which modulate the action of gamma secretase
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009US7595339 Such as N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; Cannabinoid-1 (CB1) receptor; dietetics
09/29/2009US7595317 Antiarthritic agents; rheumatoid and osteoarthritis; corneal, epidermal, or gastric ulceration; tumor metastasis or invasion; periodontal disease; and bone disease; 4-[(2-methyl-4-quinolinyl)methoxy]-N-(1,3,5-trioxo-2,4-diazaspiro[5.5]undec-7-yl)benzamide trifluoroacetate, for example
09/29/2009US7595311 Azepinoindole derivatives as pharmaceutical agents
09/24/2009WO2009115515A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists
09/24/2009WO2009115496A1 Furo [3, 2-d] pyrimidine derivatives as h4 receptor antagonists
09/24/2009WO2009115262A1 4'4'-dioxaspiro-spirocyclically substituted tetramates
09/24/2009WO2009062990A3 Equilibrative nucleoside transporter ent1 inhibitors
09/24/2009US20090239925 Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators
09/24/2009US20090239924 1h-furo[3,2-c]pyrazole compounds useful as kinase inhibitors
09/24/2009US20090239893 Synthesis of gimatecan by reacting an acetal of 7-formyl-camptothecin with O-t-butylhydroxylamine hydrochloride in a polar protic or aprotic organic solvent
09/24/2009US20090239892 Pyridomorphinans, pyridazinomorphinans and use thereof
09/24/2009US20090239871 antitumor; breast cancer; 8,9-Dimethoxy-2,3-methylenedioxy-5-[2-(N,N-dimethylamino)ethyl]-5H-dibenzo[c,h]1,6-naphthyridin-6-one
09/24/2009US20090239855 Rapamycin Analogues and the Uses Thereof in the Treatment of Neurological, Proliferative, and Inflammatory Disorders
09/24/2009US20090239301 Use of vinca alkaloids and salts thereof
09/24/2009US20090238765 Fluorescent Contrast Agent
09/24/2009CA2718735A1 4'4'-dioxaspiro-spirocyclically substituted tetramates
09/24/2009CA2717922A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists
09/23/2009EP2103615A1 4'4'-Dioxaspiro-spirocyclic substituted tetramates
09/23/2009EP2102207A1 Spiro-piperidine derivatives as via receptor antagonists
09/23/2009EP2102180A1 Substituted aminofuranones and their use
09/23/2009EP1214944B1 Composition for PERCUTANEOUS ABSORPTION with a compound having a melatonin receptor agonist activity
09/23/2009CN101541809A Spiroketone acetyl-CoA carboxylase inhibitors
09/23/2009CN101538271A Method for simultaneously extracting picrinine and ursolic acid from dita leaves
09/23/2009CN101538270A 8-alkyl galanthamine salt and preparation method and applications thereof
09/22/2009US7592352 e.g. 4-amino-3-(4-((2-fluoro-5-(trifluoromethyl)aminocarbonylamino)phenyl)-7-(3-chlorophenyl)-furo[3,2-c]pyridine; antiproliferative, anticarcinogenic, antitumor agent; solid tumor diseases, atherosclerosis, angiogenesis, vasculogenesis
09/22/2009US7592351 5,7-Dimethyl-2-thiophen-3-yl-imidazo[1,2-a]pyridin-3-yl)-(1,1,3,3-tetramethylbutyl)-amine;vanilloid/cannabinoid receptor antagonists; analgesics, neuropathic pain; headaches; antiepileptic agents; emetic agents; eating disorders; hypotensive agents; antidepressants; glaucoma; incontinence; prion disease
09/22/2009US7592350 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
09/22/2009CA2372664C Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa
09/22/2009CA2209640C Cycloalkano-pyridines
09/22/2009CA2145407C New reagents for peptide couplings
09/17/2009WO2009113389A1 Synthetic resin composition, and automotive interior/exterior material comprising the same
09/17/2009WO2009112845A1 Amido-thiophene compounds and their use
09/17/2009WO2009112839A1 Compounds
09/17/2009WO2009112826A1 Furo [3, 2-b] pyrr0l-3-0nes as cathepsin s inhibitors
09/17/2009WO2007129195A3 4-pyrimidine-5-amino-pyrazole compounds
09/17/2009US20090234114 Polymorphic forms alpha, beta, and gamma of rifaximin
09/17/2009US20090233958 (+)-beloxepin and methods for its synthesis and use
09/17/2009US20090233957 (-)-beloxepin and methods for its synthesis and use
09/17/2009US20090233841 Analgesic conjugates
09/17/2009US20090233813 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
09/17/2009CA2716679A1 Amido-thiophene compounds and their use
09/16/2009EP2100895A1 Tricyclic compound and medical use thereof
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 298